ALNA Insider Trading (Allena Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $233,465.76

Allena Pharmaceuticals Insider Trading History Chart

Allena Pharmaceuticals Share Price & Price History

^$1.81

▲ +0.17 (10.37%)

As of 02/24/2021 01:00 AM ET

Days: 30 | 90 | 365

Are you looking for the next great pet stock play?

From Emerging Markets Consulting | Ad

Don't miss this opportunity as FRPT is already trading over 100 dollars per share!

Read more here about the next great pet stock!

Allena Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/17/2020	Edward Wholihan	CFO	Sell	68,550	$1.36	$93,228.00	121,272
12/17/2020	Louis Md Brenner	CEO	Sell	103,116	$1.36	$140,237.76	144,816

SEC Filings (Institutional Ownership Changes) for Allena Pharmaceuticals (NASDAQ:ALNA)

28.03% of Allena Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Allena Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2021	Worth Venture Partners LLC	510,200	$0.65M	0.5%	+24.8%	1.332%
2/10/2021	Renaissance Technologies LLC	247,011	$0.32M	0.0%	N/A	0.645%
2/5/2021	BlackRock Inc.	164,056	$0.21M	0.0%	+21.3%	0.428%
1/25/2021	Golden Green Inc.	39,000	$50K	0.0%	N/A	0.102%
11/16/2020	Worth Venture Partners LLC	408,840	$0.61M	0.5%	+60.3%	1.068%
11/13/2020	Morgan Stanley	1,051,627	$1.56M	0.0%	-2.7%	2.746%
10/20/2020	Wedbush Securities Inc.	24,150	$36K	0.0%	-50.9%	0.063%
8/17/2020	Jacobs Levy Equity Management Inc.	126,672	$0.20M	0.0%	-28.3%	0.332%
8/14/2020	Worth Venture Partners LLC	255,000	$0.40M	0.2%	+148.1%	1.031%
8/14/2020	Sabby Management LLC	1,531,446	$2.42M	0.5%	N/A	6.190%
8/14/2020	Advisor Group Holdings Inc.	20,000	$32K	0.0%	+81.8%	0.081%
8/12/2020	Algert Global LLC	17,340	$27K	0.0%	-51.3%	0.070%
8/12/2020	Goldman Sachs Group Inc.	28,112	$44K	0.0%	N/A	0.114%
7/16/2020	Wedbush Securities Inc.	49,150	$78K	0.0%	+103.5%	0.199%
5/15/2020	Morgan Stanley	1,253,847	$1.21M	0.0%	+56.1%	5.068%
5/14/2020	Sphera Funds Management LTD.	667,800	$0.64M	0.1%	-27.2%	2.699%
5/1/2020	BlackRock Inc.	120,556	$0.12M	0.0%	-6.0%	0.487%
2/20/2020	Geode Capital Management LLC	105,854	$0.29M	0.0%	+103.0%	0.451%
2/18/2020	Algert Global LLC	36,840	$0.10M	0.0%	N/A	0.157%
2/14/2020	Goldman Sachs Group Inc.	33,784	$92K	0.0%	-59.3%	0.144%
2/13/2020	Banco Bilbao Vizcaya Argentaria S.A.	38,113	$0.10M	0.0%	N/A	0.162%
2/13/2020	Renaissance Technologies LLC	241,700	$0.66M	0.0%	+91.2%	1.030%
1/16/2020	Wedbush Securities Inc.	50,150	$0.14M	0.0%	+95.5%	0.214%
11/27/2019	Millennium Management LLC	484,625	$1.91M	0.0%	+48.8%	2.065%
10/17/2019	Wedbush Securities Inc.	25,650	$0.10M	0.0%	+66.6%	0.109%
8/16/2019	Susquehanna International Group LLP	33,565	$0.14M	0.0%	N/A	0.143%
8/15/2019	Jane Street Group LLC	28,570	$0.12M	0.0%	N/A	0.122%
8/14/2019	Morgan Stanley	1,744,095	$7.10M	0.0%	-2.3%	7.432%
8/14/2019	Paloma Partners Management Co	52,100	$0.21M	0.0%	N/A	0.222%
8/14/2019	Vanguard Group Inc.	468,190	$1.91M	0.0%	-10.2%	1.995%
8/13/2019	Jacobs Levy Equity Management Inc.	41,587	$0.17M	0.0%	+17.0%	0.177%
8/13/2019	BlackRock Inc.	115,656	$0.47M	0.0%	-81.0%	0.493%
8/13/2019	Northern Trust Corp	112,945	$0.46M	0.0%	-6.5%	0.481%
8/12/2019	Bank of New York Mellon Corp	23,719	$96K	0.0%	-24.4%	0.101%
8/7/2019	JPMorgan Chase & Co.	46,901	$0.20M	0.0%	-78.6%	0.225%
8/6/2019	Wells Fargo & Company MN	11,751	$48K	0.0%	-44.9%	0.056%
8/1/2019	Wedbush Securities Inc.	15,400	$63K	0.0%	N/A	0.074%
6/20/2019	Sphera Funds Management LTD.	431,193	$3.03M	0.3%	+24.9%	2.071%
4/1/2019	Deutsche Bank AG	28,023	$0.15M	0.0%	+8.2%	0.135%
2/14/2019	Squarepoint Ops LLC	43,500	$0.24M	0.0%	+3.8%	0.210%
2/14/2019	Perceptive Advisors LLC	132,300	$0.70M	0.0%	-47.1%	0.637%
2/14/2019	Sphera Funds Management LTD.	345,199	$1.88M	0.2%	+16.9%	1.663%
2/13/2019	Geode Capital Management LLC	72,314	$0.39M	0.0%	+8.1%	0.348%
2/11/2019	Bank of New York Mellon Corp	29,521	$0.16M	0.0%	-7.3%	0.142%
2/8/2019	BlackRock Inc.	581,971	$3.17M	0.0%	+0.8%	2.803%
2/8/2019	New York State Common Retirement Fund	12,100	$66K	0.0%	-16.0%	0.058%
1/31/2019	Rhumbline Advisers	14,349	$78K	0.0%	N/A	0.069%
1/31/2019	Fosun International Ltd	29,877	$0.15M	0.0%	N/A	0.144%
12/13/2018	Vanguard Group Inc	349,819	$3.76M	0.0%	+2.2%	1.685%
11/23/2018	Vanguard Group Inc.	349,819	$3.76M	0.0%	+2.2%	1.685%
11/20/2018	Morgan Stanley	1,856,640	$19.94M	0.0%	+126.0%	8.943%
11/14/2018	Sphera Funds Management LTD.	295,199	$3.17M	0.4%	+10.4%	1.422%
11/13/2018	Partner Fund Management L.P.	1,768,568	$18.99M	0.3%	+1.7%	8.519%
11/13/2018	Citadel Advisors LLC	10,776	$0.12M	0.0%	N/A	0.052%
11/9/2018	FMR LLC	1,489,783	$16M	0.0%	-20.2%	7.180%
11/9/2018	BlackRock Inc.	577,443	$6.20M	0.0%	+1.7%	2.783%
10/25/2018	Alps Advisors Inc.	36,722	$0.39M	0.0%	+22.3%	0.177%
9/18/2018	Northern Trust Corp	113,981	$1.49M	0.0%	+94.0%	0.549%
8/15/2018	Millennium Management LLC	219,351	$2.86M	0.0%	+138.2%	1.057%
8/15/2018	Partner Fund Management L.P.	1,739,805	$22.67M	0.4%	+18.8%	8.385%
8/15/2018	Partner Investment Management L.P.	298,005	$3.88M	3.1%	-48.2%	1.436%
8/10/2018	FMR LLC	1,865,777	$24.31M	0.0%	-15.6%	8.992%
8/9/2018	BlackRock Inc.	567,707	$7.40M	0.0%	+145.1%	2.743%
8/8/2018	Spark Investment Management LLC	16,000	$0.21M	0.0%	N/A	0.077%
8/8/2018	Schwab Charles Investment Management Inc.	21,600	$0.28M	0.0%	N/A	0.104%
8/6/2018	Bank of New York Mellon Corp	31,137	$0.41M	0.0%	+205.8%	0.150%
8/6/2018	Rhumbline Advisers	10,222	$0.13M	0.0%	N/A	0.049%
8/2/2018	Alps Advisors Inc.	30,036	$0.39M	0.0%	N/A	0.145%
7/24/2018	Acadian Asset Management LLC	18,539	$0.24M	0.0%	N/A	0.090%
5/16/2018	Millennium Management LLC	92,079	$1.02M	0.0%	+311.9%	0.445%
5/11/2018	Citadel Advisors LLC	11,265	$0.12M	0.0%	N/A	0.054%
5/10/2018	JPMorgan Chase & Co.	195,771	$2.16M	0.0%	-45.3%	0.946%
5/10/2018	Sphera Funds Management LTD.	410,199	$4.52M	0.7%	+26.2%	1.982%
5/9/2018	BlackRock Inc.	231,654	$2.55M	0.0%	+2.2%	1.119%
5/2/2018	Wells Fargo & Company MN	9,336	$0.10M	0.0%	+246.4%	0.045%
2/15/2018	Millennium Management LLC	22,356	$0.23M	0.0%	N/A	0.108%
2/14/2018	Perceptive Advisors LLC	250,000	$2.52M	0.1%	N/A	1.209%
2/14/2018	Goldman Sachs Group Inc.	49,643	$0.50M	0.0%	N/A	0.240%
2/14/2018	Deutsche Bank AG	11,846	$0.12M	0.0%	N/A	0.057%
2/14/2018	Needham Investment Management LLC	18,288	$0.26M	0.1%	N/A	0.088%
2/13/2018	Frazier Management LLC	3,330,373	$33.50M	5.4%	N/A	16.112%
2/12/2018	Sphera Funds Management LTD.	325,000	$3.27M	0.4%	N/A	1.572%
2/9/2018	BlackRock Inc.	226,775	$2.28M	0.0%	N/A	1.097%
2/9/2018	Bank of New York Mellon Corp	10,182	$0.10M	0.0%	N/A	0.049%
1/31/2018	Dean Capital Investments Management LLC	11,568	$0.12M	0.0%	N/A	0.056%

Data available starting January 2016

Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in the development and commercialization of oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. The company's lead product candidate is reloxaliase, an oral enzyme therapeutic that is in phase 3 clinical program for the treatment of hyperoxaluria, a metabolic disorder commonly associated with kidney stones in adults. It also develops ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and moderate to severe chronic kidney diseases. Allena Pharmaceuticals, Inc. was founded in 2011 and is headquartered in Newton, Massachusetts.

Today's Range

Now: $1.81

$1.71

$1.84

50 Day Range

MA: $1.75

$1.32

$2.17

52 Week Range

Now: $1.81

$0.53

$3.39

Volume

932,442 shs

Average Volume

3,285,956 shs

Market Capitalization

$69.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.39

Who are the company insiders with the largest holdings of Allena Pharmaceuticals?

Allena Pharmaceuticals' top insider shareholders include:

Louis Md Brenner (CEO)
Edward Wholihan (CFO)

Who are the major institutional investors of Allena Pharmaceuticals?

Allena Pharmaceuticals' top institutional shareholders include:

Worth Venture Partners LLC — 1.33%
Renaissance Technologies LLC — 0.65%
BlackRock Inc. — 0.43%
Golden Green Inc. — 0.10%

Which institutional investors are buying Allena Pharmaceuticals stock?

Within the last quarter, ALNA stock was acquired by institutional investors including:

Renaissance Technologies LLC
Worth Venture Partners LLC
Golden Green Inc.
BlackRock Inc.